Abstract:Abstract Background Osteosarcoma (OS) is a rare, malignant bone tumor that primarily affects adolescents and has a high degree of malignancy and high incidence of recurrence and metastasis. Our study aimed to explore the role of miR-338-3p in OS cells. Methods qRT-qPCR was performed to quantify miR-338-3p expression levels in OS tissue samples and in three common OS cell lines. MG-63 and Saos2 cells were separately transfected with miR-338-3p or NC mimics and miR-338-3p expression levels was determined by qRT-PCR. Cell proliferation was monitored using the Cell Counting Kit-8. Flow cytometer analysis was carried out to determine the distribution of cell cycle stages and apoptosis. Transwell assay was performed to measure the migratory and invasive capacities of MG-63 and Saos2 cells. The expression of Vimentin and E-cadherin was detected by western blot. Luciferase reporter assay, qRT-PCR and western blotting were performed to confirm the target of miR-338-3p. Results Analysis by qRT-PCR revealed that miR-338-3p was downregulated in the tissue samples of 20 OS patients when compared with that in their matched adjacent non-tumor tissues. Furthermore, miR-338-3p was significantly downregulated in three common OS cell lines, namely, MG-63, Saos2, and HOS, when compared with that in the human osteoblast cell line hFOB1.19. Analysis by luciferase reporter assay, qRT-PCR, and western blotting revealed that activator of 90 kDa heat shock protein ATPase homolog 1 (AHSA1) is a direct target of miR-338-3p. miR-338-3p overexpression led to significant reduction in AHSA1 protein levels in MG63 and Saos2 cells. miR-338-3p overexpression reduced cell viability and migration and invasion behavior of MG63 and Saos2 cells. In addition, miR-338-3p overexpression suppressed epithelial–mesenchymal transition (EMT), induced a significant G1-phase arrest and did not affect the apoptosis in both MG-63 and Saos2 cells. Moreover, overexpression of AHSA1 reversed the inhibitory effect of miR-338-3p overexpression on proliferation, cell cycle, apoptosis, EMT, migration, and invasion of MG63 and Saos2 cells, thereby suggesting that miR-338-3p acts as a tumor suppressor in OS cells by targeting AHSA1. Conclusions miR-338-3p/AHSA1 can serve as a potential therapeutic target for OS therapy.

MiR-361-3p Promotes Tumorigenesis of Osteosarcoma Cells Via Targeting ARID3A

MicroRNA-1236-3p Inhibits Human Osteosarcoma Growth

MicroRNA-133a Inhibits Osteosarcoma Cells Proliferation and Invasion Via Targeting IGF-1R

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and Migration

MiR-181a Promotes the Proliferation and Metastasis of Osteosarcoma Cells by Targeting RASSF1A

Downregulation of Microrna-15A-3p is Correlated with Clinical Outcome and Negatively Regulates Cancer Proliferation and Migration in Human Osteosarcoma

MicroRNA-506-3p inhibits osteosarcoma cell proliferation and metastasis by suppressing RAB3D expression

Microrna-338-3p Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma Cells by Targeting Activator of 90 Kda Heat Shock Protein ATPase Homolog 1.

Mir-34c-3p Acts As A Tumor Suppressor Gene in Osteosarcoma by Targeting Marcks

Lncrna Meg3 Negatively Modified Osteosarcoma Development Through Regulation Of Mir-361-5p And Foxm1

Expression of miR-664-3p in Osteosarcoma and Its Effects on the Proliferation and Apoptosis of Osteosarcoma Cells.

MiR-92a modulates proliferation, apoptosis, migration and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3.

MicroRNA-31 Inhibits Osteosarcoma Cell Proliferation, Migration and Invasion by Targeting PIK3C2A.

ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma

MiR-23a functions as a tumor suppressor in osteosarcoma.

The MiR-193a-5p/NCX2/AKT Axis Promotes Invasion and Metastasis of Osteosarcoma

MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion

Mir-16-5p Suppresses Progression and Invasion of Osteosarcoma Via Targeting at Smad3

Knockdown of Microrna-181A Inhibits Osteosarcoma Cells Growth and Invasion Through Triggering NLRP3-dependent Pyroptosis.